Rate this Video

RADAR-CNS: Wearable Technology for Epilepsy, Depression, and MS

RADAR-CNS (Remote assessment of disease and relapse – Central Nervous System) is a new research program supported by the Innovative Medicines Initiative (IMI) with the goal to develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.

RADAR-CNS is jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and includes 24 organizations from Europe and the US.

Visit the RADAR-CNS website to find out more:
Comments (0)
Add your comment